News » New Product Launch_碧康制药股份有限公司

Beacon Started Production of Hepatitis C Wonder Drug DacIatasvir

Daclatasvir is a new medication approved by US FDA to treat Hepatitis C. Its a research product of Bristol Myer Squibb and marketed in the brand name Daklinza.Beacon Pharmaceuticals Ltd is the 1 st global company to introduce copy of Daklin

Beacon Pharmaceuticals Limited introduces deflazacort 24 first time in Bangladesh

Beacon Pharmaceuticals Limited introduces Deflazacort INN 24 mg Tablet under the brand name of Xalcort 24.Xalcort 24 is going to be the 1 st preparation of Deflazacort 24 mg tablet in Bangladesh. Xalcort 24 is a Corticosteroidpreparationdru

Generic Revolution: Combo Blockbusters Hep C are Now at Affordable Price

Generic Revolution: Combo Blockbusters Hep C are Now at Affordable Price While every death from Hepatitis C is a human tragedy millions of people suffer chronic fatigue from the illness, often enduring decades of suffering. Considering

Multivitamin Syrup launched by Beacon

Multivitamin Syrup launched by Beacon Beacon Pharmaceuticals Limited introduces Multivitamin Syrup with Cod Liver Oil in the Brand name DORAKID (Syrup). The Syrup is a vital supplement for growing Kids. DORAKID is a multivitamin and mineral

Hexinor Syrup launched by Beacon

Hexinor Syrup launched by Beacon Beacon Pharmaceuticals Limited introduces Trihexyphenidyl Hydrochloride under the Brand name Hexinor.Hexinor is now available in syrup.Earlier Beacon has introduced Hexinor in tablet form. Hexinor is used fo

Tetrabenazine 25mg tablet launched by Beacon

Tetrabenazine 25mg tablet launched by Beacon Beacon Pharmaceuticals Limited introduces Tetrabenazine 25mg tablet under the Brand name Tetrazine 25. Tetrabenazine is a monoamine depleter.Tetrazine 25mg tablet will be used for the treatment o